Welcome to LookChem.com Sign In|Join Free
  • or
NAP 226-90-d6 is a labeled metabolite of Rivastigmine, which is a brain-selective acetylcholinesterase inhibitor. It is a white solid and serves as an active (major) metabolite of Rivastigmine.

194930-03-5

Post Buying Request

194930-03-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

194930-03-5 Usage

Uses

Used in Pharmaceutical Industry:
NAP 226-90-d6 is used as a metabolite for the development and study of Rivastigmine, a drug used to treat Alzheimer's disease and other cognitive disorders. Its role as a metabolite helps in understanding the drug's pharmacokinetics, pharmacodynamics, and potential therapeutic effects.
Used in Research and Development:
NAP 226-90-d6 is used as a research tool for studying the mechanisms of action, metabolism, and potential side effects of Rivastigmine. This information can be valuable for optimizing drug formulations, improving drug delivery systems, and developing new therapeutic strategies for Alzheimer's disease and other related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 194930-03-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,9,3 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 194930-03:
(8*1)+(7*9)+(6*4)+(5*9)+(4*3)+(3*0)+(2*0)+(1*3)=155
155 % 10 = 5
So 194930-03-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-8(11(2)3)9-5-4-6-10(12)7-9/h4-8,12H,1-3H3/i2D3,3D3

194930-03-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[1-[Di(methyl-d3)amino]ethyl]phenol

1.2 Other means of identification

Product number -
Other names 3-[1-[bis(trideuteriomethyl)amino]ethyl]phenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:194930-03-5 SDS

194930-03-5Downstream Products

194930-03-5Relevant academic research and scientific papers

Synthesis of tritium, deuterium and carbon-14 labeled (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]carbamic acid, phenyl ester, (L)-2,3-dihydroxybutanedioic acid salt (SDZ ENA 713 hta), an investigational drug for the treatment of Alzheimer's disease

Ciszewska, Grazyna,Pfefferkorn, Heidi,Tang,Jones, Lawrence,Tarapata, Richard,Sunay, Ustun B.

, p. 651 - 668 (1997)

(S)-(-)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl] carbamic acid, phenyl-2-3H-ester, (L)-2,3-dihydroxybutanedioic acid salt was synthesized via directed ortho-metallation methodology. (S)-(-)-N-Ethyl-N-methyl-3-[1-(di-(2H3)-methylamino)ethyl]carbamic acid, phenyl ester, (L)-2,3-dihydroxybutanedioic acid salt was synthesized from 3-hydroxyacetophenone. The molecule was resolved by classical diastereomeric salt formation and fractional crystallization. The carbon-14 analog, (S)-(-)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl-1-(14C)]carbamic acid, phenyl ester, (L)-2,3-dihydroxybutanedioic acid salt was constructed starting from 3-iodoanisole and featured the enantioselective reduction of a methoxylamine intermediate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 194930-03-5